We're create a computational drug discovery and target ID platform for neurodegenerative diseases1-10 Employees
- B2B
- Early StageStartup in initial stages
NeuroX1 Funding
$1.3M
11 round
NeuroX1 is active in the following markets / industries: biotechnology, pharmaceuticals, machine learning, synthetic biology, Drug development, Drug discovery and artificial intelligence / machine learning. The company has secured funding across 1 rounds, totaling in an amount of $1.3M. Their most recent funding was raised on December 30, 2021.
Funding Rounds
PRE
$1250000